Evidence map›Paper›PMID 42123146›Full record

ReviewJournal of clinical medicine2026

Management of Recurrent Venous Thromboembolism on Anticoagulation.

Jennifer Eatrides, Avani Singh, Ankita Patel, Michael Jaglal, Geetha Rajasekaran Rathnakumar, Enas Abdallah, Damian A Laber

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jennifer EatridesDepartment of Ambulatory Hematology and Oncology, H. Lee Moffitt Cancer Center, Tampa, FL 33607, USA.
Avani SinghDepartment of Ambulatory Hematology and Oncology, H. Lee Moffitt Cancer Center, Tampa, FL 33607, USA.
Ankita PatelDepartment of Ambulatory Hematology and Oncology, H. Lee Moffitt Cancer Center, Tampa, FL 33607, USA.
Michael JaglalDepartment of Ambulatory Hematology and Oncology, H. Lee Moffitt Cancer Center, Tampa, FL 33607, USA.
Geetha Rajasekaran RathnakumarDepartment of Ambulatory Hematology and Oncology, H. Lee Moffitt Cancer Center, Tampa, FL 33607, USA.
Enas AbdallahDepartment of Oncologic Sciences, University of South Florida, Tampa, FL 33612, USA.ORCID 0000-0003-0346-9886
Damian A LaberDepartment of Ambulatory Hematology and Oncology, H. Lee Moffitt Cancer Center, Tampa, FL 33607, USA.ORCID 0000-0003-1041-4429

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Direct oral anticoagulants (DOACs) are the standard first treatment for patients with venous thromboembolism. Unfortunately, some patients develop recurrent thromboembolism despite adherence to anticoagulation. This remains a significant clinical challenge with no randomized data to guide therapy. This review summarizes the available evidence for the management of recurrent venous thromboembolism (VTE) and DOAC failure, and we propose our group consensus and management algorithm.

Indexed as

DOAC failurerecurrent VTEthromboembolism on anticoagulation

Identifiers

PMID42123146
PMCPMC13163864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.